Adlai Nortye Ltd. (ANL) Financial Ratios
6 years of historical data (2019–2024) · Healthcare · Biotechnology
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
↑
4.31
↑+355% vs avg
5yr avg: 0.95
30Y Low0.8·High1.1
ROE
↑
-99.0%
↓+14% vs avg
5yr avg: -115.5%
30Y Low-132%·High-99%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
ANL Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Adlai Nortye Ltd. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Market Cap | $322M | $29M | $61M | — | — | — | — |
| Enterprise Value | $289M | $-5049407 | $1M | — | — | — | — |
| P/E Ratio → | -2.11 | — | — | — | — | — | — |
| P/S Ratio | — | — | 12.24 | — | — | — | — |
| P/B Ratio | 4.31 | 1.12 | 0.77 | — | — | — | — |
| P/FCF | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
ANL EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| EV / Revenue | — | — | 0.25 | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — |
ANL Profitability
Margins and return-on-capital ratios measuring operating efficiency
A negative ROE of -99.0% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Gross Margin | — | — | 100.1% | — | 100.0% | — | — |
| Operating Margin | — | — | -1352.2% | — | -18.9% | — | — |
| Net Profit Margin | — | — | -2099.2% | — | -124.0% | — | — |
Return on Capital
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| ROE | -99.0% | -99.0% | -132.1% | — | — | — | — |
| ROA | -51.5% | -51.5% | -103.4% | -57.6% | -67.3% | -266.6% | -165.0% |
| ROIC | -730.8% | -730.8% | -260.4% | — | — | — | — |
| ROCE | -103.8% | -103.8% | -84.6% | — | -27.5% | — | — |
ANL Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
The company holds a net cash position — cash of $61M exceeds total debt of $27M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.07 | 1.07 | 0.40 | — | — | — | — |
| Debt / EBITDA | — | — | — | — | — | — | — |
| Net Debt / Equity | — | -1.32 | -0.75 | — | — | — | — |
| Net Debt / EBITDA | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — |
| Interest Coverage | -28.22 | -28.22 | -85.40 | -155.36 | -6.46 | -14.94 | -41.01 |
Net cash position: cash ($61M) exceeds total debt ($27M)
ANL Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.41x means Adlai Nortye Ltd. can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has improved from 0.21x to 1.41x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 1.41 | 1.41 | 2.01 | 0.21 | 7.12 | 0.32 | 0.32 |
| Quick Ratio | 1.41 | 1.41 | 2.01 | 0.21 | 7.12 | 0.32 | 0.32 |
| Cash Ratio | 1.34 | 1.34 | 1.96 | 0.20 | 6.74 | 0.28 | 0.30 |
| Asset Turnover | — | — | 0.04 | — | 0.35 | — | — |
| Inventory Turnover | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | 26.23 | — | 15.41 | — | — |
ANL Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Adlai Nortye Ltd. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | — | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | — | — | — | — |
| Shares Outstanding | — | $11M | $7M | $8M | $8M | $8M | $8M |
Peer Comparison
Compare ANL with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 ANLYou | $322M | -2.1 | — | — | — | — | -99.0% | -730.8% | — |
 ZLAB | $2B | -10.7 | — | — | 58.5% | -48.6% | -22.6% | -41.7% | — |
 ZYME | $2B | -21.2 | — | — | 100.0% | -87.3% | -26.7% | -25.9% | — |
 CAN | $203M | -0.7 | — | — | 7.8% | -21.2% | -59.8% | -24.9% | — |
 IMVT | $7B | -12.1 | — | — | — | — | -64.8% | — | — |
 RCUS | $2B | -7.2 | — | — | 96.0% | -156.3% | -63.3% | -64.1% | — |
 AGEN | $137M | -970.6 | — | — | 29.6% | -18.0% | — | — | — |
 NKTR | $1B | -6.1 | — | — | 100.0% | -236.8% | -217.9% | -57.2% | — |
 MGNX | $252M | -3.4 | — | — | 71.1% | -48.7% | -86.9% | -144.1% | — |
 PFE | $149B | 19.3 | 10.6 | 16.4 | 70.3% | 24.7% | 8.9% | 7.5% | 3.3 |
 MRK | $294B | 16.4 | 11.3 | 23.8 | 72.0% | 36.2% | 36.9% | 22.0% | 1.7 |
| Healthcare Median | — | 22.9 | 14.4 | 18.9 | 63.9% | -4.3% | -32.6% | -11.4% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 6 years · Updated daily
What if you invested $1,000 in ANL 10 years ago?
Total return calculator · dividends reinvested
Calculate ReturnsHow much would $100/month in ANL be worth today?
Dollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersIs ANL Undervalued Right Now?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationANL vs ZLAB — which is the better buy?
Side-by-side revenue, margins, P/E and 10-year returns vs Zai Lab Limited.
Compare NowANL — Frequently Asked Questions
Quick answers to the most common questions about buying ANL stock.
What is Adlai Nortye Ltd.'s P/E ratio?
Adlai Nortye Ltd.'s current P/E ratio is -2.1x. This places it at the 50th percentile of its historical range.
What is Adlai Nortye Ltd.'s ROE?
Adlai Nortye Ltd.'s return on equity (ROE) is -99.0%. The historical average is -115.5%.
Is ANL stock overvalued?
Based on historical data, Adlai Nortye Ltd. is trading at a P/E of -2.1x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.